Cabot adds Graphene Technology to its Portfolio Following an Agreement with XG Sciences

SpecialChem – Nov 14, 2011 BOSTON — Cabot Corporation has added graphene technology to its portfolio, company officials announced recently. Cabot has added this emerging performance technology to its portfolio through an intellectual property licensing agreement with XG Sciences, Inc. Under the agreement, Cabot will license intellectual property rights to XG’s xGnP® graphene nanoplatelets technology,… Read More

Cabot buys graphene licence from XG Sciences

Boston, Massachussetts — Cabot Corp. Cabot has added graphene technology to its portfolio through an intellectual property licensing agreement with XG Sciences, Inc. Under the agreement, Cabot will license intellectual property rights to XG’s xGnP graphene nanoplatelets technology, including detailed know-how regarding the manufacturing process. Graphenes are highly electrically and thermally conductive, mechanically strong, thin… Read More